Field trial evaluations of a novel persistent barrier teat dip for preventing mastitis during the dry period and as a potential substitute for dry cow antibiotic therapy by Timms, Leo L.
Animal Industry Report Animal Industry Report 
AS 650 ASL R1914 
2004 
Field trial evaluations of a novel persistent barrier teat dip for 
preventing mastitis during the dry period and as a potential 
substitute for dry cow antibiotic therapy 
Leo L. Timms 
Iowa State University 
Follow this and additional works at: https://lib.dr.iastate.edu/ans_air 
 Part of the Agriculture Commons, and the Dairy Science Commons 
Recommended Citation 
Timms, Leo L. (2004) "Field trial evaluations of a novel persistent barrier teat dip for preventing mastitis 
during the dry period and as a potential substitute for dry cow antibiotic therapy," Animal Industry Report: 
AS 650, ASL R1914. 
DOI: https://doi.org/10.31274/ans_air-180814-42 
Available at: https://lib.dr.iastate.edu/ans_air/vol650/iss1/73 
This Dairy is brought to you for free and open access by the Animal Science Research Reports at Iowa State 
University Digital Repository. It has been accepted for inclusion in Animal Industry Report by an authorized editor of 
Iowa State University Digital Repository. For more information, please contact digirep@iastate.edu. 
Iowa State University Animal Industry Report 2004 Dairy
Field trial evaluations of a novel persistent barrier teat dip for
preventing mastitis during the dry period and as a potential
substitute for dry cow antibiotic therapy
A.S. Leaflet R1914
Leo Timms, Associate Professor of Animal Science
Summary and Implications
Dipping of cows at dry off and cows and heifers 10 day
prepartum until calving with a persistent barrier teat dip
product (developed and patented at ISU) in 2 natural
exposure field trials resulted in a significantly lower IMI
(particularly major environmental pathogens) at calving
compared to controls. Dipping and/or dry therapy resulted
in significantly lower new IMI in the early dry period
compared to controls, with no difference in new IMI
between treatments. Dipping of cows with a new persistent
barrier teat dip provides the first cost effective, novel dry
cow mastitis prevention tool focused at high susceptibility
times and all causative organisms, and also can be a
potential substitute for dry cow antibiotic therapy for
prevention of new early dry period IMI.  This also results in
lowering the potential risks of antibiotic contamination of
milk.
Materials and Methods
A 13 month natural exposure trial (trial 1)was
conducted using an persistent barrier teat dip .  All dry cows
and freshening heifers at the ISU Dairy Farm were used.
The trial was a half udder randomized design with either
right or left quarters dipped while the others served as
controls.  All cows were dry treated with an approved
intramammary antibiotic tube.  Cows were only dipped
once at dry off following dry cow treatment administration.
Cows and heifers were dipped starting approximately 10
days prepartum and were redipped as needed until
parturition.  Dip persistency was evaluated daily on all
animals.  Duplicate aseptic quarter milk samples were taken
at 3 days pre-dry off, dry off, calving, and 3 days
postpartum and frozen until subsequent bacteriological
analysis.  A second 14 month trial was conducted (trial 2).
Dipping and sampling were similar to trial 1 but only half
the quarters were dry treated to evaluate the potential role of
the dip as an alternative / adjunct to dry cow therapy for
prevention of early dry period IMI.  Duplicate quarter milk
samples were also taken at 14 days post dry off in this trial.
Results and Discussion
New IMI at calving for trial 1 (190 animals; 756
quarters) are shown in Table 1. Dipped quarters of heifers
showed a 19, 40, and 50% reduction in all, major
pathogen(MP), and environmental streptococcal (ES) IMI,
with no significant reduction in coagulase-negative
staphylococcal(CNS) or gram negative(G-) IMI.  Dipped
quarters of cows showed a 47, 52, 68, and 43% reduction in
all, MP, ES, and CNS IMI with no reduction in G- IMI.
Combining data from both groups shows an overall
reduction of 37, 48, 63, and 28% of all, MP, ES, and CNS
IMI in dipped quarters as compared to controls. New IMI at
calving for trial 2 (221 animals; 884 quarters) are shown in
Table 2. Dipped quarters of heifers showed a 26, 75, 75,
and 80% reduction in all, MP, G-, and ES IMI. Dipped
quarters of cows showed 34, 47, 75, and 30% reduction in
all, MP, S. aureus, and CNS IMI.  Combined data from
both groups shows a 31, 60, 57, 54, 71, and 22% reduction
in all, MP, G-, ES, S. aureus, and CNS infections. New
early dry period IMI for control, dry treated only(DCT),
dipped only(DIP), and DCT/DIP quarters are shown in
Table 3. Although infection levels for all groups were low,
all treatment groups showed significant reductions in CNS
and total IMI compared to controls, with the DCT and DIP
groups showing significant reductions (p < .1) in major
pathogens, also. No significant differences were seen across
treatment groups for all new IMI categories. All persistent
infections from dry off were CNS.
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Table 1. New intramammary infections at calving in quarters dipped with a novel persistent
              barrier teat dip and undipped control quarters for trial 1.
NG CNS SA ES G- Major All
HEIFERS  n=66; Dipped 102 21 1 5a 3 9 30
264 quarters; No Dip 95 22 2 10 3 15 37
COWS    n=124; Dipped 213 20c 1 7c 5 13c 33c
492 quarters; No Dip 184 35 0 22 5 27 62
TOTALS n=190; Dipped 315 41a 2 12c 8 22c 63c
756  quarters; No Dip 279 57 2 32 8 42 99
Table 2. New intramammary infections at calving in quarters dipped with a novel persistent
               barrier teat dip and undipped control quarters for trial 2.
NG CNS SA ES G- Major All
HEIFERS n= 78; Dipped 122 31 1 1 b 1a 3d 34a
312 quarters No Dip 110 34 3 5 4 12 46
COWS  n =143; Dipped 240 35 a 1 a 5 2 8 a 43c
572 quarters; No Dip 219 50 4 8 3 15 65
TOTALS n=221; Dipped 362 66 a 2 b 6 a 3 11 d 77 d
884 quarters No Dip 329 84 7 13 7 27 111
Group NG CNS SA ES G- major all PI
Control 94 10 1 2 1 4 14 4
DCT 105 5 a 0 1 0 1 a 6 b 1
DIP 104 4 a 0 1 0 1 a 5 c 3
DCT/DIP 108 2 c 0 2 0 2 4 c 0
NG = uninfected; CNS = coagulase negative staphylococci ; SA = Staphylococcus. aureus;
ES = Environmental streptococci; G- = gram negatives; major = major pathogen IMI;
All = all intramammary infections; PI = persistent infection from dry off .
a,b,c,d Significant lower IMI compared to controls: a(p< .1); b(p< .05); c(p< .025); d(p < .01).
